Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -113.77% | 262.21% | -7.71% | 390.52% | 230.70% |
| Total Depreciation and Amortization | 42.70% | 25.98% | 2.46% | -21.35% | -34.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 234.79% | -100.78% | -52.62% | -127.36% | -136.71% |
| Change in Net Operating Assets | -177.25% | -37.72% | -30.41% | 1,241.72% | 141.48% |
| Cash from Operations | 12.13% | 0.87% | -26.71% | -45.83% | -35.58% |
| Capital Expenditure | -- | -- | -- | -- | 10.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 20.63% | -923.56% | -923.56% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 21.88% | -933.56% | -933.56% | -- | -6,787.45% |
| Total Debt Issued | -24.41% | -- | -- | -- | -- |
| Total Debt Repaid | -74.84% | 15.80% | 45.48% | 69.22% | 76.97% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,470.73% | -1,293.07% | -382.44% | -51.10% | 80.26% |
| Cash from Financing | -134.41% | 206.75% | 195.83% | 178.16% | 129.01% |
| Foreign Exchange rate Adjustments | 247.34% | -126.09% | 975.00% | -1,092.86% | -380.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.26% | -17.11% | -17.76% | -2.74% | 234.43% |